Medtronic’s Valiant Captivia TEVAR Device to Treat Acute Complicated TBAD Evaluated at 5-Year Follow-Up
May 12, 2020—Online in Journal of Thoracic and Cardiovascular Surgery (JTCVS), Joseph E. Bavaria, MD, et al reported the 5-year outcomes of thoracic endovascular aortic repair (TEVAR) of complicated acute type B aortic dissection (TBAD) in the DISSECTION trial.
STABLE II Data Published for Cook’s Zenith Dissection Endovascular System to Treat Acute, Complicated Type B Aortic Dissections
March 25, 2020—Findings from the STABLE II clinical trial of the Zenith dissection endovascular system (Cook Medical) were published by Global Principal Investigator Joseph V. Lombardi, MD, et al in the Journal of Vascular Surgery (JVS; 2020;71:1077–1087.e2). The trial evaluated the safety and effectiveness of the Zenith dissection system’s composite device design (covered stent graft and bare-metal stent) for the treatment of patients with acute, complicated type B aortic dissection (TBAD) presenting with aortic rupture and/or branch vessel malperfusion.
American College of Surgeons Releases Clinical Guidance for Elective Surgical Case Triage During COVID-19 Outbreak
March 25, 2020—The American College of Surgeons (ACS) announced continued guidance for surgeons to curtail recommendations for elective surgical procedures to preserve the necessary resources for care of critically ill patients during the COVID-19 pandemic.
Vascular Society of Great Britain and Ireland Provides Guidelines for Managing Treatment Amid COVID-19 Pandemic
March 20, 2020—Professor Chris Imray, MD, President of the Vascular Society of Great Britain and Ireland, announced guidelines from the society to address the rapidly evolving situation regarding the COVID-19 virus as it impacts patients and the particular challenges for health care workers.
CryoLife’s E-vita Open Neo Hybrid Stent Graft Approved in Europe
March 4, 2020—CryoLife, Inc. announced that it has received European CE Mark approval for the E-vita Open Neo, a hybrid stent graft system for the treatment of aortic arch disease, including both aortic aneurysms and aortic dissections.
Vascular Medicine Consult Registry Launched for the SVS Vascular Quality Initiative
January 15, 2020—The Society for Vascular Surgery (SVS), the SVS Vascular Quality Initiative (VQI), and the American Heart Association (AHA) announced the introduction of the Vascular Medicine Consult (VMC) registry for the VQI—a collaboration of the SVS Patient Safety Organization (PSO), the Society for Vascular Medicine, and AHA.
Outcomes Published From Large Case Series of Complex AAA Treated With Terumo Aortic’s Fenestrated Anaconda Endograft
December 9, 2019—Findings from an assessment of the technical and clinical outcomes of the Fenestrated Anaconda endograft device (Terumo Aortic) in a large international case series were published online ahead of print in Journal of Vascular Surgery (JVS) by Arne de Niet, MD, et al, on behalf of the Fenestrated Anaconda Study Group.
CryoLife Receives CE Mark for E-nya Thoracic Stent Graft
December 2, 2019—CryoLife, Inc. announced it has received European CE Mark approval for the E-nya thoracic stent graft system for the minimally invasive repair of lesions of the descending thoracic aorta, including thoracic aortic aneurysms and dissections.
Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes
November 22, 2019—Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-year clinical outcomes from the ANCHOR registry evaluating the company’s Heli-FX EndoAnchor system in patients with hostile neck abdominal aortic aneurysms (AAAs) at the VEITHsymposium held November 19–23 in New York, New York.
Terumo Acquires Aortica Corporation to Further Bolster Its Vascular Graft Portfolio
November 20, 2019—Terumo Corporation announced the acquisition of Aortica Corporation, which developed the AortaFit automated case planning software to match fenestrations on an endograft with unique locations for each of a patient's branch arteries during fenestrated endovascular aneurysm repair (FEVAR) cases.
Endospan's Nexus Arch Branch Stent Graft System Studied at 2 Years
November 5, 2019—VIVA Physicians announced that 2-year results from a prospective, multicenter, premarket study composed of 25 patients (mean age, 73 years) treated with the Nexus aortic arch stent graft (Endospan) were presented by Daniel Clair, MD, in a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada.
Medtronic's Valiant Navion TEVAR Device Approved and Launched in Japan
October 31, 2019—Medtronic announced the launch of the Valiant Navion thoracic stent graft in Japan, where the Ministry of Health, Labour and Welfare granted it Shonin approval for the endovascular repair of thoracic descending aortic aneurysms and complicated type B aortic dissections (TBADs).
Medtronic Gains FDA Breakthrough Device Designations for Valiant TAAA and Valiant Navion LSA Systems
October 8, 2019—Medtronic announced the receipt of FDA Breakthrough Device designations for the company’s Valiant thoracoabdominal aortic aneurysm (TAAA) stent graft system and the Valiant Navion left subclavian artery (LSA) branch thoracic stent graft system.
Sponsored by Cook Medical
November 2019 Supplement
Sponsored by Cook Medical
November 2019 Supplement
Controversies in Dissection Repair: Addressing Paraplegia
A review of this devastating complication including incidence rates after TEVAR for TBAD and the roles of left subclavian artery revascularization, aortic coverage, and cerebrospinal fluid drainage.
By Keagan Werner-Gibbings, MS, FRACS, and Bijan Modarai, PhD, FRCS
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.